Sonja Merkas
Scientific Advisory Board of Chemistry Today
Biography
Her contact with oligos started with her PhD and PostDoc in 2003, and continued with invaluable 10 years of experience with nucleic acid therapeutics at Novartis.
For the past 3 years, she has dedicated herself to sharing her learnings and expertise with companies, CDMOs, startups and investors in the realization of potential therapeutics and their business growth.
Sonja’s focus is mainly on CMC, development & manufacturing, business and operations improvements and transformations, BD, E2E supply chain, and project & program management.
